Full implementation of electronic product information (ePI) on medicines in the EU may not be achieved until 2030, according to a survey conducted by the European R&D-based pharmaceutical industry federation, EFPIA.
As part of the shift to ePI, a pilot scheme in Belgium and Luxembourg on switching from paper to electronic patient information leaflets (e-PILs) has been extended to August 2022 on the back of positive interim results showing that the vast majority of
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?